Patent Resources Group (PRG): Pharma and Biotech Patents: A Hatch-Waxman and BPCIA (Biosimilars) Immersion Course Encompassing Prosecution Strategies, FDA Regulation, Post-Grant Challenge, and Litigation

Fish attorneys Janis Fraser (Boston), Dorothy Whelan (Twin Cities), Terry Mahn (DC) and Martina Tyreus Hufnal (Delaware) will present Pharma & Biotech Patents: A Hatch-Waxman and PCIA (Biosimilars) Immersion Course Encompassing Prosecution Strategies, FDA Regulation, Post-Grant Challenge, and Litigation for the 2017 Patent Resources Group (PRG) Advanced Courses Program, April 2-4 in Orlando, Florida.

The course starts with a broad survey of the Hatch-Waxman and BPCIA legislation provisions that underpin the strategies to be discussed throughout the course. The course then conveys both fundamentals and advanced legal strategies in three major areas: (1) pharmaceutical and biotech patent prosecution; (2) litigation and appeal; and (3) post-grant challenges such as inter partes review and post-grant review.

It will also provide valuable, practical information for the patent practitioner, whether in-house or in private practice, to use in maximizing protection of biotechnology and pharmaceutical inventions with an eye to possible future enforcement and post-grant validity challenges.

For more information, or to register, click here.

PRG Spring 2017 Advanced Courses Program
April 2-4, 8:15AM - 3:45PM ET
Hyatt Regency Grand Cypress Resort & Spa
One Grand Cypress Blvd, Orlando, FL

Speakers:

Janis Fraser (Principal, Boston)
Martina Tyreus Hufnal(Principal, Wilmington, DE)
Terry Mahn (Principal, Washington, DC)
Dorothy Whelan (Principal, Twin Cities)